TY - JOUR
T1 - Detecting fetal DNA from dried maternal blood spots
T2 - Another step towards broad scale non-invasive prenatal genetic screening and feasible testing
AU - Bischoff, Farideh Z.
AU - Dang, Dianne X.
AU - Marquez-Do, Deborah
AU - Martinez, Denisse
AU - Horne, Cassandra
AU - Lewis, Dorothy E.
AU - Simpson, Joe Leigh
N1 - Funding Information:
We thank Audrey Burke, MS for collection of maternal blood spot specimens. This work was supported by NIH/NICHD contract #N01-HD-43202.
PY - 2003
Y1 - 2003
N2 - Both intact fetal cells and cell-free fetal DNA are present in the maternal circulation and have been used for non-invasive prenatal genetic diagnosis. However, broad clinical application awaits development of robust methods for collecting, transporting and enriching maternal blood samples to recover rare fetal cells. To circumvent this impediment, we have devised a reliable method of fetal DNA detection using dried maternal blood spots and real-time polymerase chain reaction. Fetal Y-specific (DYS1) sequences were detected in all 19 (100%) maternal blood specimens from women carrying male fetuses, in genome equivalents of 4.20-24.68 per ml of blood; the ubiquitous glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene, reflecting both maternal and fetal DNA, concurrently showed 43,684 to 680,357 genome equivalents per ml of blood. The results demonstrate that fetal DNA detection using dried maternal blood spots is highly feasible and easily adaptable for population screening.
AB - Both intact fetal cells and cell-free fetal DNA are present in the maternal circulation and have been used for non-invasive prenatal genetic diagnosis. However, broad clinical application awaits development of robust methods for collecting, transporting and enriching maternal blood samples to recover rare fetal cells. To circumvent this impediment, we have devised a reliable method of fetal DNA detection using dried maternal blood spots and real-time polymerase chain reaction. Fetal Y-specific (DYS1) sequences were detected in all 19 (100%) maternal blood specimens from women carrying male fetuses, in genome equivalents of 4.20-24.68 per ml of blood; the ubiquitous glyceraldehyde 3-phosphate dehydrogenase (GAPDH) gene, reflecting both maternal and fetal DNA, concurrently showed 43,684 to 680,357 genome equivalents per ml of blood. The results demonstrate that fetal DNA detection using dried maternal blood spots is highly feasible and easily adaptable for population screening.
KW - Cell-free fetal DNA
KW - Dried blood spots
KW - Non-invasive prenatal diagnosis
KW - Real-time PCR
UR - http://www.scopus.com/inward/record.url?scp=0038575284&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038575284&partnerID=8YFLogxK
U2 - 10.1016/S1472-6483(10)61856-1
DO - 10.1016/S1472-6483(10)61856-1
M3 - Article
C2 - 12735873
AN - SCOPUS:0038575284
SN - 1472-6483
VL - 6
SP - 349
EP - 351
JO - Reproductive BioMedicine Online
JF - Reproductive BioMedicine Online
IS - 3
ER -